/PRNewswire/ miR Scientific, LLC, a healthcare company dedicated to transforming global cancer management by providing early and highly accurate detection,.
Share this article
Share this article
NEW YORK, Jan. 11, 2021 /PRNewswire/ miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that its Chairman & CEO, Sam Salman, will be virtually presenting at the 39th Annual J.P. Morgan Healthcare Conference. Mr. Salman will introduce miR Scientific s proprietary, highly accurate, award winning sncRNA interrogation platform, highlight its recent FDA breakthrough designation and present miR s commercial launch plans for its non-invasive liquid biopsy urine test. Mr. Salman will also introduce clinical collaboration roadmaps, the company s product pipeline and global growth initiatives.